FineMark National Bank & Trust’s TherapeuticsMD TXMD Stock Holding History

FineMark National Bank & Trust’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,000	Closed	-$38K	–	454
2022 Q1	$38K	Hold	2,000	–	–	﹤0.01%	441
2021 Q4	$36K	Hold	2,000	–	–	﹤0.01%	455
2021 Q3	$74K	Hold	2,000	–	–	﹤0.01%	436
2021 Q2	$119K	Hold	2,000	–	–	﹤0.01%	436
2021 Q1	$134K	Buy	+2,000	New	+$157K	0.01%	426

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

FineMark National Bank & Trust's TXMD Position: Q2 2022 in Review

FineMark National Bank & Trust sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 2,000 shares — an estimated $38K sold.

FineMark National Bank & Trust first reported a position in TXMD in Q1 2021 and held it in 5 quarters. The position peaked at $134K in Q1 2021. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

FineMark National Bank & Trust reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
FineMark National Bank & Trust sold 2,000 TherapeuticsMD shares in Q2 2022, an estimated $38K.
FineMark National Bank & Trust first reported a position in TherapeuticsMD in Q1 2021 and held it in 5 quarters.
FineMark National Bank & Trust's TherapeuticsMD position peaked at $134K in Q1 2021.
53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on FineMark National Bank & Trust's 13F filing for Q2 2022, filed 9 Aug 2022.